begonia: datopotamab deruxtecan and durvalumab in metastatic triple-negative breast cancer
Published 1 year ago • 595 plays • Length 3:22Download video MP4
Download video MP3
Similar videos
-
1:24
begonia: durvalumab dato-dxd in advanced tnbc
-
1:30
begonia: durvalumab combinations in advanced tnbc
-
2:05
tropion-breast04: dato-dxd and durvalumab in tnbc or hr-low/her2- breast cancer
-
1:13
tropion-pantumor01: datopotamab deruxtecan in advanced her2 breast cancer
-
0:48
tropion-pantumor03: datopotamab deruxtecan in advanced solid tumors
-
1:37
tropion-lung01 & tropion-lung05: datopotamab deruxtecan for nsclc
-
1:36
efficacy of datopotamab deruxtecan, a trop2 adc, in ansclc
-
1:08
neoadjuvant durvalumab shows benefit in triple-negative breast cancer
-
1:36
real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
-
3:02
pros from tropion-breast01: datopotamab deruxtecan in hr /her2- breast cancer
-
1:25
dato-dxd: a new adc on the block
-
3:03
phase ii trial of patritumab deruxtecan in metastatic breast cancer
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
1:16
ongoing studies for datopotamab deruxtecan in nsclc
-
1:02
challenges in identifying predictive markers to icis in triple-negative breast cancer
-
1:08
updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
-
2:30
impassion130: immunotherapy for tnbc